Form 4 for LUNG Pulmonx Corp
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-01 · accession 0001209191-21-054860 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-03 | 2021-09-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $40.09 | -355 | 166.8K | -0.2% | -$14.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-01 | S | D | 355 | $40.09 | 166,814 | D | — | — | (F2) Includes 284 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on August 13, 2021. |